Perspectives towards predictive testing in Huntington disease

Neurology India

Volumn 54, Issue 4, 2006, Pages 359-362

  Nagaraja, S M ^a   Jain, Sanjeev ^a   Muthane, Uday B ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH AND NEUROSCIENCES   (India)

Author keywords

Attitudes; Genetic counseling; Huntington's disease; Presymptomatic testing

Indexed keywords

ADULT; ARTICLE; ATTITUDE TO HEALTH; CONTROLLED STUDY; DIAGNOSTIC TEST; FAMILY; FEMALE; GENETIC COUNSELING; HEALTH CARE; HUMAN; HUNTINGTON CHOREA; INDIA; MALE; NORMAL HUMAN; PHYSICIAN; PHYSICIAN ATTITUDE; PREDICTION; QUESTIONNAIRE; SOCIAL ASPECT;

EID: 33845347346     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: 10.4103/0028-3886.28105     Document Type: Article

References (19)

1. Advisory Committee on Genetic Testing (ACGT). Ref Type: Internet Communication. Department of Health: UK; [cited 1999 Mar 4].
2. Almqvist EW, Bloch M, Brinkman R, Craufurd D, Hayden MR. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease. Am J Hum Genet 1999;64:1293-304.
3. Lapham EV, Kozma C, Weiss JO. Genetic discrimination: Perspectives of consumers. Science 1996;274:621-4.
4. Hopper K, Wanderling J. Revisiting the developed versus developing country distinction in course and outcome in schizophrenia: Results from Isos, the who collaborative followup project. International study of Schizophrenia. Schizophr Bull 2000;26:835-46.
5. Ragothaman M, Govindappa ST, Rattihalli R, Subbakrishna DK, Muthane UB. Direct costs of managing Parkinson's disease in india: Concerns in a developing country. Mov Disord 2006;21:1755-8.
6. Guidelines for the molecular genetics predictive test in Huntington's Disease. International Huntington Association (IHA) and the World Federation of Neurology (WFN) Research Group on Huntington's Chorea. Neurology 1994;44:1533-6.
7. International Huntington Association and the World Federation of Neurology Research Group on Huntington's Chorea. Guidelines for the molecular genetics predictive test in Huntington's disease. J Med Genet 1994;31:555-9.
8. Harper PS, Lim C, Craufurd D. Ten Years of presymptomatic testing for Huntington's disease: The Experience of the UK Huntington's Disease Prediction Consortium. J Med Genet 2000;37:567-71.
9. Mandich P, Jacopini G, Di Maria E, Sabbadini G, Abbruzzese G, Chimirri F, et al. Predictive testing for Huntington's disease: Ten years' experience in two Italian centres. Ital J Neurol Sci 1998;19:68-74.
10. Barette J, Marsden CD. Attitudes of families to some aspects of Huntington's chorea. Psychol Med 1979;9:327-36.
11. Teltscher B, Polgar S. Objective knowledge about Huntington's disease and attitudes towards predictive tests of persons at risk. J Med Genet 1981;18:31-9.
12. Went L. Ethical issues policy statement on huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology. J Med Genet 1990;27:34-8.
13. Babul R, Adam S, Kremer B, Dufrasne S, Wiggins S, Huggins M, et al. Attitudes toward direct predictive testing for the Huntington Disease Gene. Relevance for Other Adult-Onset Disorders. The Canadian collaborative group on predictive Testing for Huntington Disease. JAMA 1993;270:2321-5.
14. Thies U, Bockel B, Bochdalofsky V. Attitudes of neurologists, psychiatrists and psychotherapists towards predictive testing for Huntington's disease in Germany. J Med Genet 1993;30:1023-7.
15. Parker M, Lucassen A. Working towards ethical management of genetic testing. Lancet 2002;360:1685-8.
16. Sharpe NF. The duty to recontact: Benefit and harm. Am J Hum Genet 1999;65:1201-4.
17. Hakimian R. Disclosure of Huntington's disease to family members: The dilemma of known but unknowing parties. Genet Test 2000;4:359-64.
18. Wertz DC, Reilly PR. Laboratory policies and practices for the genetic testing of children: A Survey of the helix network. Am J Hum Genet 1997;61:1163-8.
19. Bird SJ. Genetic testing for neurologic diseases. A rose with thorns. Neurol Clin 1989;7:859-70.